Trial Profile
Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 04 Jun 2011 New trial record